Oncogenicitiy Comparison of Human Papillomavirus Type 52 E6 Variants

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Human papillomavirus (HPV) infection is a primary cause of cervical cancer globally.
• The E6 oncoprotein of HPV plays a key role in cancer development.
• HPV-52 is prevalent worldwide, particularly in East Asia, with potential variations in oncogenicity.

Purpose of the Study:

• To compare the oncogenic potential of HPV-52 E6 oncoprotein from the prototype and three common variants (V1, V2, V3).
• To investigate molecular and phenotypic differences among HPV-52 E6 variants.

Main Methods:

• Molecular and phenotypic analyses were used to assess E6 variant oncogenicity.
• Assays included colony formation, cell migration, and cell immortalization.
• Protein complex formation, degradation of substrates (p53, MAGI-1c, Dlg), subcellular localization, and half-life were examined.

Main Results:

• HPV-52 E6 variant V1 demonstrated increased colony formation and cell migration compared to other variants.
• No significant differences in cell immortalization ability were observed among the variants.
• All tested HPV-52 E6 variants efficiently formed complexes with E6AP and p53, degraded key proteins, and showed similar subcellular localization and half-life.

Conclusions:

• HPV-52 E6 variants exhibit distinct oncogenic properties, with V1 showing enhanced proliferative and migratory potential.
• These findings contribute to understanding the high prevalence of HPV-52 in East Asian cervical cancers.
• Further research into HPV-52 E6 variant oncogenicity is warranted.